Anbio Biotechnology (NASDAQ:NNNN) Trading 7.8% Higher – Should You Buy?

Anbio Biotechnology (NASDAQ:NNNN) traded up 7.8% during mid-day trading on Wednesday . The company traded as high as $5.89 and last traded at $6.0160. 79,806 shares traded hands during mid-day trading, an increase of 3% from the average daily volume of 77,437 shares. The stock had previously closed at $5.58.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Anbio Biotechnology Price Performance

The firm’s 50 day moving average price is $8.27 and its two-hundred day moving average price is $17.78.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.